Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Catalyst Biosciences Inc (NASDAQ:CBIO)

1.63
Delayed Data
As of May 27
 +0.03 / +1.87%
Today’s Change
1.30
Today|||52-Week Range
21.60
-47.92%
Year-to-Date
No recent news for Catalyst Biosciences Inc.

Today’s Trading

Previous close1.60
Today’s open1.69
Day’s range1.61 - 1.83
Volume109,804
Average volume (3 months)15,906
Market cap$15.8M
Dividend yield34.93%
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+50.96%
Earnings growth (this year)+18.02%
Earnings growth (next 5 years)+35.40%
Revenue growth (last year)+536.36%
P/E ratioNM
Price/Sales7.92
Price/Book0.50

Competitors

 Today’s
change
Today’s
% change
EPRSEPIRUS Biopharmaceut...+0.03+4.75%
ACSTAcasti Pharma Inc+0.01+0.67%
NEOTNeothetics Inc+0.08+6.78%
BLPHBellerophon Therapeu...-0.03-2.52%
Data as of 4:00pm ET, 05/27/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.8M
Annual profit (last year)-$14.8M
Net profit margin-843.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nassim Usman
Chief Financial Officer &
Head-Investor Relations
C. Fletcher Payne
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs